Prosecution Insights
Last updated: April 18, 2026
Application No. 18/267,521

LOW-MOLECULAR-WEIGHT ORGANIC RESIN AND AQUEOUS DISPERSION COMPRISING SAME, FOR A ONE-COMPONENT CROSSLINKABLE COATING COMPOSITION

Non-Final OA §102
Filed
Jun 15, 2023
Examiner
AMATO, ELIZABETH KATHRYN
Art Unit
1762
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Arkema France
OA Round
1 (Non-Final)
82%
Grant Probability
Favorable
1-2
OA Rounds
3y 2m
To Grant
84%
With Interview

Examiner Intelligence

Grants 82% — above average
82%
Career Allow Rate
18 granted / 22 resolved
+16.8% vs TC avg
Minimal +2% lift
Without
With
+2.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
36 currently pending
Career history
58
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
60.7%
+20.7% vs TC avg
§102
15.9%
-24.1% vs TC avg
§112
19.3%
-20.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 22 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-10 and 14-18 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kanda (US 20160333219 A1). Regarding claims 1, 3, 8-10, 14-15, Kanda teaches an aqueous coating composition including acrylic urethane copolymer particles with graft acrylic resin having weight average molecular weight of 5,000 or more, plus a reactive-group containing resin, and optional crosslinking agent (Abstract). The crosslinking agent may be adipic acid dihydrazide (p. 16, [0225]). The particles may be dispersed in water (p. 11, [0145]). The acrylic urethane copolymer may contain carboxy-containing unsaturated monomers and carbonyl-containing unsaturated monomers (p. 3-4, [0037]). The urethane portion may be contributed by a carboxy-containing compound and an amine neutralizer, which may be dimethylaminoethanol (p. 6, [0085]-[0086]). The second polymer (graft acrylic resin) may contain unsaturated monomers having carboxy groups and carbonyl groups (p. 9, [0119]; claim 4). Kanda further teaches that the acid number of the final resin may be in the range of 10-100 mg KOH/g (p. 11, [0143]). The weight average molecular weight of the particles may be 5,000-50,000 (p. 10, [0141]). These prior art ranges overlap all claimed ranges with sufficient specificity to anticipate them. See MPEP 2131.03. Regarding claim 2, Kanda remains as applied to claim 1 above. Kanda further teaches that the final resin may be composed of a hydrophilic chain and a hydrophobic chain, each made from unsaturated monomers (p. 7, [0102]-[0103]). Regarding claim 4, Kanda remains as applied to claim 1 above. Kanda's hydrophobic component corresponds to the claimed P1, and may contain methyl (meth)acrylate and (meth)acrylamide (p. 8, [0115]). Methyl (meth)acrylate is a C1-C2 alkyl methacrylate monomer, and (meth)acrylamide is a carbonyl-functionalized ethylenically unsaturated monomer. Regarding claim 5, Kanda remains as applied to claim 1 above. Kanda's hydrophilic component corresponds to the claimed P2, and may contain methyl methacrylate, lauryl methacrylate, vinyltriacetoxysilane, and maleic anhydride (p. 9, [0121]). Methyl methacrylate is a C1-C2 alkyl methacrylate monomer, lauryl methacrylate is a C10-C14 alkyl (meth)acrylate monomer, vinyltriacetoxysilane is a carbonyl-functionalized ethylenically unsaturated monomer, and maleic anhydride is a carboxy-functionalized ethylenically unsaturated monomer. Regarding claim 6, Kanda remains as applied to claim 1 above. Kanda further teaches that the two polymers may be present in mass ratios ranging from 50/50 to 95/5 (hydrophobic/hydrophilic) (p. 10, [0132]). Kanda's hydrophilic polymer corresponds with the claimed carboxyl-functional P2. This translates to mass ratios of P1/P2 ranging from 50/50 to 95/5. This prior art range overlaps the claimed range with sufficient specificity to anticipate the claimed range. See MPEP 2131.03. Regarding claim 7, Kanda remains as applied to claim 1 above. Kanda further teaches that the acrylic component has a glass transition temperature of -60 to 60 *C (p. 5, [0068]). This prior art range overlaps the claimed range with sufficient specificity to anticipate the claimed range. See MPEP 2131.03. Regarding claims 16-18, Kanda remains as applied to claims 1, 8, and 14 above. Kanda further teaches a method of forming a coating film by applying the aqueous coating dispersion, which already contains the crosslinking agent (claims 1 and 6). The coating may be applied to a variety of substrates including metal, concrete, wood, and plastic (p. 17, [0248]). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ELIZABETH K AMATO whose telephone number is (571)270-0341. The examiner can normally be reached 8:30 am - 4:30 pm M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Rob Jones can be reached at (571) 270-7733. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. ELIZABETH K. AMATO Examiner Art Unit 1762 /ROBERT S JONES JR/Supervisory Patent Examiner, Art Unit 1762
Read full office action

Prosecution Timeline

Jun 15, 2023
Application Filed
Apr 03, 2026
Non-Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12545753
CURABLE COMPOSITION
2y 5m to grant Granted Feb 10, 2026
Patent 12540232
ELASTOMERIC COMPOSITION REINFORCED WITH GROUND-BIOCHAR
2y 5m to grant Granted Feb 03, 2026
Patent 12516160
Method for Preparing Super Absorbent Polymer
2y 5m to grant Granted Jan 06, 2026
Patent 12503600
THERMALLY CONDUCTIVE SILICONE POTTING COMPOSITION AND CURED PRODUCT THEREOF
2y 5m to grant Granted Dec 23, 2025
Patent 12473434
Composition for Liquid-Based Additive Manufacturing
2y 5m to grant Granted Nov 18, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
82%
Grant Probability
84%
With Interview (+2.1%)
3y 2m
Median Time to Grant
Low
PTA Risk
Based on 22 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month